Cargando…
The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access
BACKGROUND: The reform of pharmaceutical policy can often involve trade-offs between competing social and commercial goals. Canada's Access to Medicines Regime (CAMR), a legislative amendment that permits compulsory licensing for the production and export of medicines to developing countries, a...
Autores principales: | Esmail, Laura C, Kohler, Jillian Clare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388467/ https://www.ncbi.nlm.nih.gov/pubmed/22472291 http://dx.doi.org/10.1186/1744-8603-8-7 |
Ejemplares similares
-
Canada's implementation of the Paragraph 6 Decision: is it sustainable public policy?
por: Cohen-Kohler, Jillian C, et al.
Publicado: (2007) -
WTO accession and firm exports in developing economies
por: Nuruzzaman, N., et al.
Publicado: (2021) -
Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders
por: Kohler, Jillian, et al.
Publicado: (2022) -
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
por: Esmail, Laura C, et al.
Publicado: (2010) -
TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?
por: Kerry, Vanessa Bradford, et al.
Publicado: (2007)